Catheter-Directed Thrombolysis Market Size

Catheter-Directed Thrombolysis Market size was over USD 453.2 million in 2023 and is likely to reach USD 931.68 million by 2036, witnessing around 5.7% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of catheter-directed thrombolysis is assessed at USD 473.87 million. The growth of the market is primarily attributed to the increasing prevalence of pulmonary embolism and deep vein thrombosis (DVT) amidst increasing number of stroke issues. For instance, every year approximately 900,010 number of people affected by deep vein thrombosis (DVT) or pulmonary embolism (PE).

Catheter-directed thrombolysis is a prominent treatment to treat blood vessel clots by improving blood flow and deterring tissue damage. Thrombolysis is a sort of minimally invasive endovascular therapy. It primarily includes injecting clot-busting drugs through an intravenous (IV) line or a catheter-directed thrombolysis (CDT) device, which supplies the drugs directly to the blocking sites for anticoagulation. Catheter-directed thrombolysis device consists an X-Ray camera, catheter, special medicines, and a medical device used to disperse blood clots. CDT devices are safer than traditional surgical intervention such as surgical balloon thrombectomy, allowing for shorter hospital stays while reducing patient trauma and health issues.As per the data provided by the National Center for Biotechnology Information, trauma is the major cause of death among young adults and accounts for 10% of all deaths in men and women. Every year, approximately 50 million people visit the emergency department in the United States owing to trauma.